PF-Atlas › Clinical Trials › NCT04497831
Morphine for Dyspnea in Pulmonary Fibrosis
Morphine hydrochloride · Phase 3
Registry ID
NCT04497831
Phase
Phase 3
Status
Unknown
Drug / intervention
Morphine hydrochloride
Sponsor
Medical University of Gdansk
Start
2020-09-21
Enrollment
20
About this trial
"Determination of the effectiveness of nebulized morphine in the treatment of dyspnea in patients with advanced idiopathic pulmonary fibrosis"
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04497831 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.